As of Apr 26, 2024, the DGX stock has a PE ratio of 17.83. The calculation is based on the latest EPS of $7.53 and the stock price of $134.26 per share. A decrease of 3.4% has been observed in the PE ratio compared to its average of 18.5 of the last four quarters.
The mean historical PE ratio of Quest Diagnostics over the last ten years is 16.03. The current 17.83 P/E ratio is 11% higher than the historical average. Looking back at the last ten years, DGX's PE ratio peaked in the Jun 2017 quarter at 21.88, with a price of $111.16 and an EPS of $5.08. The Jun 2021 quarter marked the lowest point at 7.74, with a price of $131.97 and an EPS of $17.06.
Maximum annual increase: 82.59% in 2014
Maximum annual decrease: -33.17% in 2020
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 18.17 | -5.9% |
| 2022 | 19.31 | 76.83% |
| 2021 | 10.92 | -2.67% |
| 2020 | 11.22 | -33.17% |
| 2019 | 16.79 | 8.67% |
| 2018 | 15.45 | -11.66% |
| 2017 | 17.49 | -12.86% |
| 2016 | 20.07 | 38.8% |
| 2015 | 14.46 | -17.42% |
| 2014 | 17.51 | 82.59% |
DGX's current PE ratio is higher than the 3, 5 and 10-year averages.
DGX's PE ratio stands lower than its peer stocks LH and QGEN, but it is higher than ENZ's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ENZ Enzo Biochem Inc | 1.57 | $53.79M |
| DGX Quest Diagnostics Inc | 17.83 | $14.92B |
| QGEN Qiagen NV | 27.77 | $9.5B |
| LH Laboratory Corp Of America Holdings | 41.33 | $16.69B |
| NEO Neogenomics Inc | N/A | $1.8B |
| TBIO Telesis Bio Inc | N/A | $9.63M |
DGX's price to earnings ratio is 17.83 as of Apr 26, 2024.
Over the last 3 years, the average price to earnings ratio for DGX stock is 14.36.
Over the last 5 years, the average price to earnings ratio for DGX stock is 14.83.
Over the last ten years, the Jun 2017 quarter recorded the highest quarterly PE ratio at 21.88.
DGX's current price to earnings ratio is 11% above its 10-year historical average.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Apr 26, 2024), Quest Diagnostics's share price is $134.26. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $7.53. Therefore, Quest Diagnostics's PE ratio for today is 17.83. PE RATIO(17.83) = STOCK PRICE($134.26) / TTM EPS($7.53)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.